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ABSTRACT
Objective: To compare two suites of culture media (one with HSA and one protein-free
(PF) supplemented with methylcellulose) for washing human sperm in IVF.
Methods: Semen samples (n = 41) underwent parallel density gradient preparation using
PF or HSA-supplemented culture medium and subsequent yield, survival, morphology
and motility were compared.
Results: The PF medium resulted in a significantly higher sperm yield (P < 0.0001), but
similar sperm morphology (P = 0.822) and 24-h survival (P = 0.11). There was, however,
a lower percentage of progressively motile sperm (P < 0.0001) and a higher proportion of
sperm demonstrating non-progressive motility (P < 0.0001) in the PF medium when
observed on a Makler Chamber, apparently an artefact as a similar sperm motility index
was measured using a Sperm Quality Analyser (P = 0.83). Attachment of sperm in PF
medium to the glass chamber reduced with time and any differences had disappeared after
6 min on the counting chamber.
Conclusion: These results support the use of PF media supplemented with methylcel-
lulose as an alternative to HSA, although a modification to the manufacturer's protocol of
6-min pre-incubation before assessing sperm motility must be used. Further studies
should investigate the function of such sperm prepared in PF medium.
1. Introduction
The desire to use serum-free medium exists in a number of
industries, ranging from the pharmaceutical industry where there
is a need to produce biopharmaceutical products free of infec-
tious agents [1,2], to the area of toxicity testing, in which novel
protein biomarkers of cells in culture need to be monitored
with minimal background contamination [3]. But with over
70 000 treatment cycles and 13 000 babies born each year in
Australia alone following the culture of human embryos
in vitro [4], assisted reproductive technology (ART) is a major
user of medium which, when used to culture preimplantation
embryos for less than one week after fertilisation, can have
profound effects on the health and characteristics of the foetus
and children later in life [5–9].
IVF medium must be safe and effective [10], and over the
years has contained protein supplemented in the form of
patient serum through to human serum albumin (HSA) as a
means of improving the growth of the embryos [11].
Nevertheless, the various protein supplements have each
presented their own problems regarding safety with pooled
patient serum having resulted in the transmission of hepatitis
B to recipients [12] and a batch of HSA prepared from donated
blood having been withdrawn because of a donor having been
found to be infected with Creutzfeld–Jakob disease [13]. Whilst
albumin can have significant batch-to-batch variability [14],
HSA is beneficial in improving fertilisation, cleavage and
pregnancy rates [15] but even current day practices of HSA
purification still results in the presence of a large variety of
non-declared proteins of unknown consequences to the health
of patients and future offspring [16,17]. Given the aforementioned
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limitations and risks of the use of human serum albumin in ART,
some interest has been shown in the identification and/or
development of more stable and safer alternatives. There are
several macromolecules derived from non-animal sources that
have been investigated for use as a supplement for ART culture
media [18–20], though many of these alternatives are yet to be
incorporated into commercially available culture media and
adopted into routine clinical use. One exception, however, is
methylcellulose: a non-toxic, non-allergenic, non-carcinogenic,
non-infectious, plant-derived macromolecule with antioxidant
and osmolytic properties [21]. A formulation of IVF medium
which contains methylcellulose and is truly protein-free has
shown excellent results in preliminary trials [22–24], although
experience with a commercially-available version has not been
so encouraging [25].
Whilst a commercially-available protein-free ART medium
would have merit, the ability of such a medium to support the
many steps involving gametes and embryos in an IVF procedure
must be demonstrated, and given the apparent lack of in-
vestigations into same, a systematic appraisal of the various in-
dividual steps is warranted. The aim of the present study was,
therefore, to assess the effectiveness of a commercially-available
protein-free medium and its associated density gradient system
when applied to sperm preparation in terms of sperm yield,
motility, morphology and motility maintenance in culture, and to
compare this to a commercially-available suite of culture media
supplementedwithHSA as theymight be used in a clinical setting.
2. Materials and methods
2.1. Study design
The present study involved the analysis and parallel prepa-
ration of semen samples from men attending Fertility North for
fertility assessment between August and December 2013. The
study design ensured that each sample was prepared in an
identical fashion using both media types to allow direct com-
parison, using only one sample per man to avoid pseudo-
replication. The study was approved by the Joondalup Health
Campus Human Research Ethics Committee and the Ethics
Committee of Edith Cowan University, and all participants
provided informed consent for their samples to be utilised in the
research.
2.2. Collection of semen
Semen samples were obtained over the full period of the
study from a total of 41 men (average ± SEM age of 35.4 ± 1.0
years). Each man was instructed to abstain from ejaculation for
2–5 days and then produce a semen sample by masturbation into
a wide-mouthed, 60 mL sterile specimen container (TechnoPlas,
Australia). After production, each sample was held in a warming
oven (Memmert, Germany) at 37 C for a maximum of
60 min until analysis and processing.
2.3. Semen and sperm assessment
All semen samples underwent routine semen analysis
following protocols employed routinely by the clinic, which are
based upon the methods described in the World Health Orga-
nisation Guidelines [26]. Washed sperm were assessed using
the same methodology. To reflect clinical practice, sperm
concentration was determined for each sample at a dilution of
1:20 using an Improved Neubauer Haemocytometer. A 50 mL
aliquot of neat semen or the final sperm suspension was added
to 950 mL of water and mixed well to ensure the suspension
was evenly distributed. Then 10 mL of this diluted suspension
was pipetted under the cover slip of each chamber of the
haemocytometer and allowed to settle for 5 min in a
humidified chamber, before the sperm were counted. Sperm
morphology was evaluated by making duplicate air-dried
smears and staining with DiffQuick® (Bactolaboratories,
Australia). A minimum of 200 sperm were assessed at ×400
magnification under brightfield illumination, and the proportion
of sperm with normal morphology expressed as a percentage of
the total number of sperm assessed. For the assessment of sperm
motility, 10 mL of neat semen or the final sperm suspension was
aliquoted onto the surface of a Makler chamber (Sefi Medical
Instruments Ltd, Israel) and the cover slip put in place. At least
200 sperm were observed at 200× using phase-contrast micro-
scopy, and their motility categorised as rapid progressive (“A”),
slow progressive (“B”), non-progressive (“C”) or immotile
(“D”). In addition, sperm motility was assessed in some samples
using an automated Sperm Quality Analyser (SQA IIB, Medical
Electronic Systems, Israel). This form of assessment uses deep
chambers and the instrument detects movement of sperm sus-
pended in medium by measuring light scatter and calculating a
sperm motility index (SMI) [27].
2.4. Sperm preparation and culture
Two suites of culture media were used, one supplemented
with HSA (Quinn's Advantage HSA [#3001] and Quinn's
Advantage Medium with Hepes [#1023], Sage Biopharma,
USA; Puresperm® #PS100-250, Nidacon, Sweden) and the other
being protein-free (CellCura® PF Protein Free GradiART™
Upper and lower Layer Medium [#GP21050 and #GP31050],
PF Protein Free Gamete Handling Medium with HEPES and
Gentamicin [#GP700500], CellCura, Norway). All preparations
were performed “blind” so the scientist doing the work was
unaware which preparation was HSA or PF.
Following routine semen analysis, all 41 semen samples
underwent parallel density gradient preparation in each suite of
media. Depending on the volume of semen available, between
0.5 and 1.0 mL semen was applied to discontinuous gradients of
equal volumes (1 ml each) of 95% and 50% Puresperm or Upper
and Lower CellCura gradients in conical centrifuge tubes
(#352095, Falcon Corning, USA). The same volume of semen
was applied to each of the two types of gradients to avoid dis-
crepancies. Each gradient tube was centrifuged (#C28A, Boeco,
Germany) at 350 g for 15 min. The resulting pellet was removed
and resuspended in a clean Falcon tube (352095, Falcon Corn-
ing, USA) in 2 mL of the corresponding culture media: Sage
(HSA) or CellCura (PF). Each suspension was washed by
centrifugation, at 500 g for 5 min. The supernatant was removed
by aspiration with a clean Pasteur pipette (PPB-150-100-PL,
Hunter, Australia) and resuspended with another 2 mL of the
corresponding culture media: HSA or PF. Each suspension then
underwent a final wash, at 500 g for 5 min. The supernatant was
removed and the pellet resuspended in 0.3 mL of HSA or PF
media and the suspension was examined microscopically at
200× (phase-contrast, 20× objective, 10× ocular) (#BX50F,
Olympus, Australia) and resulting sperm motility and concen-
tration then manually assessed.
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Following the trial preparation described above, 20 of the
duplicate preparations were cultured in Falcon tubes (#352095,
Falcon Corning, USA) overnight at room temperature. Twenty-
four hours later, sperm motility and the calculated motility
maintenance (=final progressive motility*100% initial progres-
sive motility) of the sperm in each culture media were manually
assessed.
2.5. Exposure to anti-static measures
Following trial preparation, the HSA and PF suspensions of
11 samples were manually assessed for sperm motility on mi-
croscope slides (Knittel, Germany) that had been subjected to
antistatic treatments in the 5 min preceding the motility assess-
ment, namely (i) wiped slides had been treated with an anti-static
Superfine Fibre Cloth (GGS Photographic Equipment Company,
China), and (ii) slides had been treated with Distinct Anti-Static
Screen Cleaning fluid (E3! Style Product Specialists, Brisbane,
Australia).
2.6. Statistical analysis
The differences between the experimental and control groups
were compared for statistical significance with the Paired Stu-
dent's t-test using the StatistXL (StatistXL, Western Australia,
2009) add-in to Excel (Microsoft Office, Microsoft Corporation,
2010). Differences were considered significant if P < 0.05.
3. Results
3.1. Initial density gradient preparations sperm culture
The overall results of the semen preparation using HSA-
supplemented and PF media for all 41 samples are shown in
Table 1. Analysis of the total number of sperm recovered from
each media suite showed that PF preparation resulted in
significantly higher numbers of sperm compared with the HSA
suite (P < 0.05) and consequently a higher yield from the semen
(P < 0.05). A slight but significant improvement in sperm
morphology was noted for both gradients compared to the
original semen (both P < 0.05) although they did not differ
between themselves. Compared to the semen, both gradients
resulted in higher proportions of sperm with progressive (A + B)
motility and fewer immotile (D) sperm (both P < 0.05). How-
ever, there did appear to be a difference in the motility profiles of
the sperm recovered from the two different media suites, with PF
suspensions demonstrating a lower proportion of sperm with
“A + B” type motility and a greater proportion of “C” type
motile sperm. The proportion of immotile sperm was not
significantly different between the two preparation types.
A subset of 20 prepared pairs of samples were cultured at
room temperature overnight and the motility and percentage
sperm motility maintenance were assessed as shown in Table 2.
The proportion of immotile sperm was the same for both sys-
tems, but once again the proportion of “A + B” motile sperm at
24 h was greater in those suspensions prepared using the HSA
suite of media whilst there was more “C” type motility observed
in the PF suspensions. Whilst the survival of sperm seemed to be
superior in the HSA suspensions, this difference was not sta-
tistically significant.
3.2. Factors affecting sperm motility profile
The increased proportion of sperm showing “C” grade
motility in the PF medium, as described above, was eventually
noticed to be associated with sperm sticking to the glass of the
Makler chamber. In an attempt to explain this, sperm motility
was further assessed in a sub-set of 9 sperm suspensions using
the SQA II automated analyser as shown in Table 3. Despite the
samples processed using the PF gradient again showing the same
pattern of lower progressive and higher non-progressive motility
than the HSA gradients preparations when manually assessed on
the Makler chamber, the SQA demonstrated no significant dif-
ference in the SMI between the two media suites (P = 0.83).
Table 1
The preparation of washed sperm by discontinuous gradients with suites
of media either containing human serum albumin (HSA media; Medicult
medium and Puresperm) or being protein-free (PF media: CellCura media
and gradient). Values are mean ± sem for 41 samples from 41 men.
Sperm parameter Original semen Final preparation
HSA media PF media
Sperm concentration
(×106/mL)
87.8 ± 10.2 – –
Total sperm loaded/
recovered (×106)
77.2 ± 9.0 14.9 ± 2.1 23.1 ± 2.8*
Normal forms (%) 10.7 ± 1.3 13.4 ± 2.7 13.6 ± 2.3
Motility (%) A + B 57.2 ± 2.2 83.9 ± 2.6 71.3 ± 2.4*
C 7.6 ± 0.7 8.1 ± 1.3 24.1 ± 2.2*
D 34.3 ± 1.9 8.4 ± 2.3 5.1 ± 1.2
Yield (%) – 20.5 ± 2.6 31.7 ± 4.0*
* P < 0.05 between the HSA and protein-free medium.
Table 2
The motility and motility maintenance (mean ± SEM) of washed sperm
cultured for 24 h following preparation in HSA-containing and protein-
free media. A total of 20 samples from 20 men were processed, and
sperm survival in culture was defined as the final motility × 100/initial
motility.
Sperm parameter HSA media PF media
0 h 24 h 0 h 24 h
Motility: A + B (%) 83.9 ± 2.6 57.3 ± 4.9* 71.3 ± 2.4 39.6 ± 5.9*
C (%) 8.1 ± 1.3 16.6 ± 1.9* 24.1 ± 2.2 35.5 ± 4.5*
D (%) 8.4 ± 2.3 25.8 ± 4.1* 5.1 ± 2.5 26.6 ± 5.5*
Survival (%)a – 68.0 ± 5.3 – 57.7 ± 7.5
*Results for the same preparation method after 24 h in culture are
significantly different (P < 0.05).
a Survival = final motility ×100/initial progressive motility (motility
maintenance).
Table 3
The motility (mean ± SEM) of sperm prepared using HSA-containing and
protein-free media when assessed both manually and with the Sperm
Quality Analyser (n = 9 semen samples from 9 men).
Motility assessment (%) Media suite
HSA Protein-free
Manual A + B 90.8 ± 2.9 73.1 ± 4.4*
C 4.9 ± 1.9 23.2 ± 3.3*
D 4.2 ± 1.9 3.8 ± 1.6
SQA analyser Sperm motility index 452.4 ± 43.9 470.1 ± 36.8
*P < 0.05 between the HSA and protein-free medium.
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To endeavour to determine whether static electricity may
have caused adherence of sperm to the glass microscope slide
during motility assessment, and hence an apparent increase in
“C” type motility, the slides used to assess 11 pairs of washed
preparations were exposed to 2 antistatic measures as shown in
Table 4. The results indicate that the antistatic spray and wipes
both increased the proportion of sperm with “C” type motility in
the HSA-containing medium, and did not improve the situation
in the PF medium.
Sperm motility in PF medium was opportunistically noticed
to improve in PF medium when viewed on a microscope slide
left on the bench. In a final attempt to ensure the difference in
motility patterns between the two different media was not a
simple artefact, motility was manually assessed at 0, 3 and
6 min after loading of the glass slides in a subset of 11 samples
as shown in Table 5. While statistically significant differences
between patterns of sperm motility are apparent in the different
media types at the early time intervals, these differences appear
to resolve over time. Samples therefore processed on the two
sets of gradients and assessed 6 min after loading on to the
Makler chamber, as shown in Figure 1, were similar for both
media types.
4. Discussion
The use of serum to supplement the culture of mammalian
embryos dates back to the 1960s when it was discovered that the
addition of rabbit or bovine serum to culture media significantly
increased the proportion of blastocysts formed [28], and the early
work on human IVF used patient serum as a supplement to the
medium [29]. Serum is thought to help create an environment that
more closely resembles that of the female reproductive tract that
may improve the rate of cleavage, encourage activation of the
embryonic genome and enhance the embryos' implantation
potential [30], and because of its complex composition, human
serum added to culture media can act as a buffer, helping to
minimise fluctuations in pH, whilst the amino acids contained
within it may supplement the activity of those amino acids
already separately added to culture media and it may also help
bind any heavy metals [31]. In addition to its effect on
embryos, the presence of serum appears to facilitate the
process of capacitation and/or the acrosome reaction of sperm,
which is essential to enable them to fertilise an oocyte in vitro
[32,33]. Serum in culture also appears to reduce the incidence
of DNA damage in sperm and increase the rate of cleavage in
human embryos [34]. At a practical level, serum also prevents
gametes and embryos from becoming sticky and difficult to
handle in culture, thus facilitating their manipulation in culture
and preventing them from adhering to the plastic and
glassware used [35].
The use of serum has been criticised because, being a bio-
logical solution, its composition is difficult to define, can be
subject to significant variation, and may include components that
impact on embryonic development such as hormones, vitamins,
fatty acids and ions [14,36]. When used as a supplement in
assisted reproductive technology, there is the compounding
problem that the maternal serum from some women, such as
those with endometriosis, may contain elements that are
embryotoxic [37]. Perhaps more importantly, the use of serum,
both from animal and human origins, has also been criticised
because of the risk of disease transmission. In spite of donor
screening processes, in 1991 in the Netherlands, 79 IVF
patients contracted Hepatitis B following the culture of their
embryos in culture media containing pooled serum that had
been contaminated by the Hepatitis B virus [12] and, more
recently, it was revealed that a commercially-available HSA
product had potentially been contaminated following the death
of an albumin donor due to the infectious Creutzfeldt–Jakob
Disease (CJD) prion [13].
In the quest to remove serum from IVF culture medium, a
version of medium without serum has been used [38]. However,
human serum albumin in one form or another, but still derived
from blood, is predominantly used to supplement ART culture
media in the hope that it provides a better defined medium
Table 4
Motility of sperm (mean ± SEM) prepared using HSA-containing and
protein-free media on slides when assessed on microscope slides pre-
treated with anti-static spray or wipes (n = 11).
Motility grade Spray pre-treatment Wipe pre-treatment
HSA Protein-free HSA Protein-free
A + B (%) 53.1 ± 3.4 41.0 ± 4.2* 55.3 ± 3.6 43.0 ± 4.4
C (%) 36.0 ± 2.9 45.8 ± 4.4 36.0 ± 3.1 49.8 ± 3.8*
D (%) 9.8 ± 2.1 11.1 ± 3.1 9.6 ± 1.2 7.3 ± 1.6
*Significant P < 0.05.
Table 5
The assessment of motility (mean ± SEM) at different times after loading on to a microscope slide. Sperm from 11 ejaculates produced by 11 men were
prepared and cultured in both HSA-containing and protein-free media.
Time (mins) HSA media PF media
A + B C D A + B C D
0 84.7 ± 3.7 7.5 ± 2.4 7.9 ± 3.5 74.9 ± 2.7 21.1 ± 3.0* 3.6 ± 1.0
3 85.6 ± 4.1 8.1 ± 2.6 7.1 ± 3.7 71.0 ± 3.4* 25.4 ± 3.6* 3.6 ± 1.2
6 85.2 ± 3.5 7.0 ± 2.1 8.3 ± 3.2 86.8 ± 2.0 9.4 ± 1.9 3.4 ± 0.9
*P < 0.05 comparing HSA-containing and protein-free media.
Figure 1. The motility of sperm from 11 semen samples prepared using
density gradients and resuspended in medium either containing human
serum albumin (HSA) or being protein-free (PF). Sperm motility was
assessed 6 min after loading on to the microscope slide.
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and elicits improved results [15,30,39–41], although there is some
concern that serum supplementation yields better results than
protein supplementation alone and the latter may be suitable
only in conjunction with additional components [42].
Recombinant albumin has been used in cell culture because of
the concerns over transmissible spongiform encephalopathies
[2], and it has also been used in a general IVF setting [43] as
well as the special case of Jehovah's witnesses [44].
Nevertheless, the use of non-protein macromolecules has been
investigated for use as a supplement for ART culture media in an
attempt to avoid the problems associated with blood products,
such as the addition of polyvinyl alcohol (PVA) [45],
polyvinylpyrolidone (PVP) [46] and dextran [18] to aid with the
potential handling differences when HSA is not incorporated
into culture media. However, the teratological safety of the
likes of PVA and PVP is uncertain [47].
Methylcellulose has been shown to be a suitable macro-
molecule to support gametes and embryos [22,23] and following
patenting of a formulation [21] this has now been placed in to
commercial production and marketed by Cellcura®. The
availability of such a medium would appear to be a step
forward but a recent clinical trial had to be cancelled due to
poor performance of the medium [25]. It was unclear whether
this was due to issues with the formulation, manufacture or
shipment, but the satisfactory performance of the formulation
reported earlier [22–24] cannot be ignored. The usefulness of
the medium is best confirmed by a systematic evaluation of
the methylcellulose-supplemented medium in the key steps of
the ART process, rather than just an overview of the overall
process. The aim of the present study, therefore, was to inde-
pendently assess the effectiveness of the medium using density
gradients, a routine sperm preparation technique employed by
many clinics worldwide, in terms of sperm yield, motility, sur-
vival and morphology. One suite of media used was supple-
mented traditionally with HSA; the other with the plant-derived
macromolecule, methylcellulose.
The results of the present study confirmed that the yield of
sperm using the PF suite of gradients and medium was satisfac-
tory. However, the main limitation was the artefact in assessing
sperm motility. There was an apparent increase in the proportion
of non-progressively motile sperm but this was not apparent with
the deep chamber used with the SQA sperm analyser, and
resolved itself on glass slides by simply waiting for 6 min and
allowing the sperm to detach themselves from the glass surface.
As mentioned above, the “stickiness” of cells is relieved by the
inclusion of protein [35], but equally a revised protocol using the
PF medium was effective. However, regulatory authorities (e.g.
the Therapeutic Goods Administration, TGA, in Australia)
require such a modification to be documented in the
manufacturer's Instructions for Use (see https://www.tga.gov.
au/publication/australian-regulatory-guidelines-medical-devices-
argmd) and this was not provided. The use of the suite of PF
media under sub-optimal conditions will bias the findings of
laboratories and may result in erroneous conclusions on the
suitability of the media for clinical use. These findings raise the
question of whether modifications are required at other stages of
gamete culture, and so further systematic studies on different
aspects of use of the media with sperm are warranted.
In summary, the present study has confirmed that the use of a
commercially-available protein-free suite of media can result in
good preparations of washed sperm, but that a modified protocol
must be used to assess sperm motility in order to avoid the
artefact of sperm sticking to the microscope observation cham-
ber. While these results support the use of methylcellulose as an
alternative to HSA, albeit it with a modified protocol, further
studies on the functional capacity of the sperm are required.
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